Protara Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 3.40 M | $17.95 M | 78.95% | 15.23% |
JANUS HENDERSON GROUP PLC | 02/14/2025 | 2.27 M | $11.94 M | 100.00% | 10.17% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 2.25 M | $11.88 M | 100.00% | 10.08% |
TORONTO DOMINION BANK | 02/19/2025 | 2.09 M | $11.03 M | 100.00% | 9.35% |
OPALEYE MANAGEMENT INC. | 02/14/2025 | 1.83 M | $9.64 M | 8.56% | 8.17% |
BLACKSTONE INC. | 02/14/2025 | 1.68 M | $8.87 M | 100.00% | 7.52% |
VELAN CAPITAL INVESTMENT MANAGEMENT LP | 02/14/2025 | 1.58 M | $8.34 M | 175.09% | 7.07% |
SIO CAPITAL MANAGEMENT, LLC | 02/14/2025 | 1.44 M | $7.59 M | 100.00% | 6.44% |
INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 1.40 M | $7.39 M | 100.00% | 6.27% |
VANGUARD GROUP INC | 02/11/2025 | 1.36 M | $7.18 M | 78.97% | 6.09% |
02/14/2025 | 1.28 M | $6.76 M | 100.00% | 5.73% | |
02/14/2025 | 1.09 M | $5.75 M | 100.00% | 4.88% | |
CITADEL ADVISORS LLC | 02/14/2025 | 1.03 M | $5.43 M | 50.99% | 4.60% |
WOODLINE PARTNERS LP | 02/14/2025 | 853,160 | $4.50 M | 0.19% | 3.82% |
5AM VENTURE MANAGEMENT, LLC | 02/14/2025 | 800,000 | $4.22 M | 100.00% | 3.58% |
BAKER BROS. ADVISORS LP | 02/14/2025 | 536,832 | $2.83 M | 0.00% | 2.40% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 517,152 | $2.73 M | 100.00% | 2.32% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 371,453 | $1.96 M | 2,479.18% | 1.66% |
SUPERSTRING CAPITAL MANAGEMENT LP | 02/14/2025 | 360,000 | $1.90 M | 100.00% | 1.61% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 350,489 | $1.85 M | 125.09% | 1.57% |
STEMPOINT CAPITAL LP | 02/14/2025 | 332,394 | $1.76 M | -64.75% | 1.49% |
WALLEYE CAPITAL LLC | 02/13/2025 | 220,814 | $1.17 M | 100.00% | 0.99% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 218,473 | $1.15 M | 100.00% | 0.98% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 203,225 | $1.07 M | 100.00% | 0.91% |
OPPENHEIMER & CO INC | 02/05/2025 | 201,426 | $1.06 M | 12.45% | 0.90% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 194,397 | $1.03 M | 53,013.93% | 0.87% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 179,593 | $948,351 | 5.62% | 0.80% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 151,906 | $802,064 | 100.00% | 0.68% |
UBS GROUP AG | 02/14/2025 | 149,408 | $788,875 | 1,914.13% | 0.67% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 142,300 | $751,344 | -57.74% | 0.64% |
J. GOLDMAN & CO LP | 02/14/2025 | 141,748 | $748,429 | 100.00% | 0.63% |
ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 122,690 | $647,803 | 100.00% | 0.55% |
BLACKROCK, INC. | 02/07/2025 | 116,037 | $612,675 | -0.80% | 0.52% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 107,800 | $569,184 | 100.00% | 0.48% |
MORGAN STANLEY | 02/14/2025 | 99,527 | $525,503 | 100.00% | 0.45% |
BARCLAYS PLC | 02/13/2025 | 93,239 | $492,000 | 100.00% | 0.42% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 88,941 | $469,608 | 411.21% | 0.40% |
STATE STREET CORP | 02/14/2025 | 82,200 | $434,016 | 209.02% | 0.37% |
683 CAPITAL MANAGEMENT, LLC | 02/14/2025 | 62,429 | $329,625 | 100.00% | 0.28% |
CITADEL ADVISORS LLC | 02/14/2025 | 56,400 | $297,792 | 3,033.33% | 0.25% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 49,300 | $260,304 | 100.00% | 0.22% |
TRUIST FINANCIAL CORP | 01/31/2025 | 40,000 | $211,200 | 0.00% | 0.18% |
JANE STREET GROUP, LLC | 02/14/2025 | 37,734 | $199,235 | 100.00% | 0.17% |
COMMONWEALTH EQUITY SERVICES, LLC | 02/10/2025 | 37,000 | $195,000 | 90.45% | 0.17% |
LPL FINANCIAL LLC | 02/11/2025 | 36,000 | $190,080 | -21.74% | 0.16% |
GSA CAPITAL PARTNERS LLP | 02/07/2025 | 35,547 | $188,000 | 100.00% | 0.16% |
BAILARD, INC. | 02/05/2025 | 29,769 | $157,180 | 100.00% | 0.13% |
NORTHERN TRUST CORP | 02/14/2025 | 28,713 | $151,605 | -0.91% | 0.13% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 25,000 | $132,000 | -49.19% | 0.11% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 20,997 | $110,864 | 100.00% | 0.09% |
Protara Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 64 institutional investors and hedge funds held shares of Protara Therapeutics, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 3.4 M
JANUS HENDERSON GROUP PLC: 2.27 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 2.25 M
TORONTO DOMINION BANK: 2.09 M
Opaleye Management Inc.: 1.83 M
Blackstone Inc.: 1.68 M
132.87% of Protara Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 28.57 M shares in the last 24 months. This purchase volume represents approximately $111.41 M in transactions.